Pharma Brand Strategy and Commercialization
Our depth and breadth of therapeutic expertise and institutional knowledge of key stakeholders helps life science companies uncover actionable insights, which along with data and analytics, inform integrated and de-risked commercial strategy and execution of each brand.
250 conditions supported across 40 therapeutic areas
270 engagements in the last 5 years
100+ pre-commercial assets supported in the last 5 years
Project Types
Strategic Solutions to Build, Differentiate, and Commercialize Your Brand
Brand Strategy
- Brand Planning
- Positioning / Message Testing
- Strategic Segmentation (HCP, Patient, Payer)
- Competitive Strategy / Workshops
- Demand Forecasts
Commercialization
- Go-To-Market Model
- Organizational Design
- Integrated Launch Roadmap
- Launch KPIs
Approach to Brand Strategy Consulting and Commercialization
Positioning & Message Testing
Objective
Develop and align on a singular brand identity statement and supporting narrative with consideration to the product’s differentiation and value in the market through comprehensive primary market research
Approach
Facilitate internal cross-functional workshop to review and align on potential positioning statements and/or messages for testing, target stakeholder audience, and competitor strategies
Prepare for and conduct 1:1 primary research with key physician and patient stakeholder segments to elicit feedback on positioning, concepts and/or messages to determine how unique, distinct, powerful, and/or convincing they are to each stakeholder
Evaluate and prioritize positioning statements, marketing concepts, and/or product messages based on their ability to be differentiated, ownable, aspirational, and sustainable
Synthesize research insights to develop an informed analysis and provide recommendations to inform the brand strategy and maximize the commercial opportunity
Go-to-Market Model
Objective
Craft a brand or portfolio level “go-to-market” strategy for asset(s) with a focus on identifying critical success factors and strategic initiatives for each functional discipline
Approach
Profile the market landscape with a focus on trends across channels, stakeholder engagement and activation opportunities, and policy trends that influence brand utilization, coverage, and access
Conduct benchmarking assessment to outline the go-to-market strategies employed to successfully launch assets
Understand market influences on brand utilization across channels through analysis of claims data
Conduct primary research with key stakeholders to pressure test preliminary hypotheses regarding best practices and critical success factors
Create an integrated evidence package, including key functional disciplines and highlight interdependencies across functions, align allocation (%) of budget/resources
Deliver final report with Recommendations, Timelines, and Next Steps
Brand Strategy & Commercialization FAQs
How does Triangle Insights Group approach brand strategy and commercialization for cell and gene therapies?
We take a holistic, decision-driven approach to commercialization that spans positioning, pricing, access, and channel strategy. For cell and gene therapies, this means designing pathways to adoption that account for clinical complexity, site-of-care constraints, reimbursement dynamics, and long-term value. Our goal is to ensure the product is set up to reach patients efficiently and sustainably.
How do you translate complex science into actionable commercialization strategy?
Rather than focusing only on messaging, we translate complex science into clear implications for positioning, value demonstration, and access strategy. This includes identifying which clinical attributes matter most to payers and providers, how durability and outcomes should be framed in economic terms, and how those insights inform pricing, evidence generation, and stakeholder engagement.
How do you account for small patient populations and specialized treatment centers?
Our brand strategies reflect the unique dynamics of cell and gene therapy markets, including concentrated prescriber bases, treatment centers of excellence, and highly engaged patient communities. Our approach ensures that access, logistics, and engagement strategies are aligned to enable efficient patient flow and appropriate utilization.
How do you integrate brand strategy with access, evidence, and launch planning?
Brand strategy is built through the integration of evidence strategy, pricing, and market access planning. We align clinical evidence with payer expectations, define pricing and contracting approaches that reflect therapy value and risk, and sequence launch activities to reduce access barriers. This creates a cohesive plan that supports both initial uptake and long-term sustainability.
How do you help ensure alignment across internal teams executing the commercialization strategy?
We develop structured commercialization frameworks that are easily usable for cross-functional decision making among R&D, Medical Affairs, Market Access, Commercial teams and more. By clearly defining the value story, evidence priorities, and access strategy, we enable teams to make consistent, coordinated decisions and execute effectively across the product lifecycle.